SecurityTRHC / Tabula Rasa HealthCare, Inc. (873379101)
Institutional Owners121 (30 N-Q Owners)
Institutional Shares11,829,491 - 21.83% (ex. N-Q)
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value54,180,000 shares (as of 2017-12-31)
Institutional Value$ 9,879,773,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) has 121 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 11,829,491 shares. Largest shareholders include Radius Venture Partners III, LLC, Knowlton Calvin H, Hood River Capital Management LLC, Ranger Investment Management, L.P., Wellington Management Group LLP, Vanguard Group Inc, BlackRock Inc., Jennison Associates Llc, Emerald Advisers Inc/pa, and Marshall Wace North America L.P..

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.


File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-02-26 N-Q Allianz Funds Multi-strategy Trust (see advisory)
2018-04-16 13F-HR PEREGRINE CAPITAL MANAGEMENT LLC 325,191 309,613 -4.79 9,122 12,013 31.69
2018-02-08 13F-HR MCKINLEY CAPITAL MANAGEMENT LLC /DELAWARE 42,862 1,203
2018-02-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 14,824 15,215 2.64 396 427 7.83
2018-03-05 13F-HR/A-1 BNP PARIBAS ARBITRAGE, SA 899 2,057 128.81 24,039 57,699 140.02
2018-02-09 13F-HR Royce & Associates LLC 50,000 1,403
2018-02-27 N-Q Northern Funds (see advisory)
2018-02-05 13F-HR CADENCE CAPITAL MANAGEMENT LLC 59,724 21,680 -63.70 1,597 608 -61.93
2018-02-27 N-Q Blackstone Alternative Investment Funds (see advisory)
2018-02-28 N-Q Gps Funds I (see advisory)
2018-04-19 13F-HR State of Alaska, Department of Revenue 1,210 46
2018-02-09 13F-HR AMERICAN INTERNATIONAL GROUP INC 6,248 6,502 4.07 167 182 8.98
2018-02-27 N-Q Massmutual Select Funds (see advisory)
2017-10-30 N-Q Franklin Alternative Strategies Funds (see advisory)
2017-11-07 13F-HR Russell Investments Group, Ltd. 94,089 0 -100.00 1,415 0 -100.00
2018-02-14 13F-HR BARCLAYS PLC 217 7,552 3,380.18 6 212 3,433.33
2018-02-14 13F-HR Squarepoint Ops LLC 12,586 353
2018-02-14 13F-HR SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 160,000 4,488
2018-01-17 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 18,300 17,000 -7.10 490 477 -2.65
2018-02-06 13F-HR EMERALD MUTUAL FUND ADVISERS TRUST 237,543 242,543 2.10 6,352 6,803 7.10
2018-02-15 13F-HR SYMMETRY PEAK MANAGEMENT LLC 22,000 0 -100.00 588 0 -100.00
2018-03-29 13F-HR/A-1 Marshall Wace North America L.P. 383,235 10,749
2018-02-14 SC 13G/A Radius Venture Partners III, LLC 1,842,301 1,185,301 -35.66
2018-02-14 13F-HR METROPOLITAN LIFE INSURANCE CO/NY 7,156 3,527 -50.71 191 99 -48.17
2018-02-14 13F-HR FRIESS ASSOCIATES LLC 29,966 295,068 884.68 801 8,277 933.33
2018-02-13 13F-HR Allianz Asset Management AG 142,144 194,604 36.91 3,801 5,459 43.62
2018-02-12 13F-HR CITIGROUP INC 0 974 0 27
2018-02-14 13F-HR FORMULA GROWTH LTD 40,000 1,122
2018-02-14 13F-HR Ameritas Investment Partners, Inc. 404 799 97.77 9 22 144.44
2017-11-14 13F-HR Sio Capital Management, LLC 312,630 0 -100.00 4,705 0 -100.00
2018-02-13 13F-HR Legal & General Group Plc 1,592 2,419 51.95 43 69 60.47
2018-02-14 13F-HR MACQUARIE GROUP LTD 26,302 738
2018-02-09 13F-HR UBS ASSET MANAGEMENT AMERICAS INC 340,774 9,558,711
2017-11-13 N-Q Managed Portfolio Series (see advisory)
2018-02-07 13F-HR Hood River Capital Management LLC 754,259 883,290 17.11 20,169 24,776 22.84
2018-02-13 13F-HR Wellington Management Group LLP 918,542 629,692 -31.45 24,561 17,663 -28.09
2018-02-14 13F-HR VANGUARD GROUP INC 362,732 562,205 54.99 9,699 15,770 62.59
2017-11-29 N-Q Amg Funds Iii (see advisory)
2018-02-28 N-Q Ishares Trust (see advisory)
2018-02-12 13F-HR AMERIPRISE FINANCIAL INC 43,505 1,220
2018-01-25 13F-HR JENNISON ASSOCIATES LLC 398,455 412,387 3.50 10,655 11,567 8.56
2017-11-29 N-Q Vanguard Index Funds (see advisory)
2017-11-09 13F-HR TFS CAPITAL LLC 11,693 0 -100.00 176 0 -100.00
2018-02-09 13F-HR CITADEL ADVISORS LLC 12,172 341
2018-02-14 13F-HR Venator Capital Management Ltd. 198,920 223,462 12.34 5,319 6,268 17.84
2017-11-22 N-Q Bridgeway Funds Inc (see advisory)
2018-02-13 13F-HR NEXT CENTURY GROWTH INVESTORS LLC 27,572 89,719 225.40 737 2,516 241.38
2018-02-28 N-Q Rydex Dynamic Funds (see advisory)
2018-01-26 N-Q Sei Catholic Values Trust (see advisory)
2018-02-14 13F-HR Parallax Volatility Advisers, L.P. 1,428 40
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ 363 14
2018-02-12 13F-HR EAM Investors, LLC 146,992 178,588 21.50 3,931 5,009 27.42
2018-02-01 13F-HR Granite Investment Partners, LLC 28,656 804
2018-02-15 13F-HR CASTLEARK MANAGEMENT LLC 227,926 6,393
2017-11-29 N-Q Vanguard Valley Forge Funds (see advisory)
2018-02-08 13F-HR WELLS FARGO & COMPANY/MN 12,768 16,100 26.10 341 452 32.55
2018-02-14 13F-HR NORTHERN TRUST CORP 106,071 110,295 3.98 2,836 3,094 9.10
2017-12-14 N-Q Ranger Funds Investment Trust (see advisory)
2018-02-14 13F-HR WADDELL & REED FINANCIAL INC 141,711 357,911 152.56 3,789 10,040 164.98
2018-02-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 24,913 25,255 1.37 666 708 6.31
2018-02-28 N-Q Rydex Series Funds (see advisory)
2017-10-30 N-Q Oppenheimer Global Multi Strategies Fund (see advisory)
2017-11-08 13F-HR ICON ADVISERS INC/CO 45,445 0 -100.00 684 0 -100.00
2018-02-14 13F-HR BlueCrest Capital Management Ltd 8,432 237
2018-02-14 13F-HR DRIEHAUS CAPITAL MANAGEMENT LLC 17,495 25,448 45.46 468 714 52.56
2018-02-14 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 31,899 895
2018-02-14 13F-HR DEUTSCHE BANK AG\ 8,315 21,293 156.08 221 596 169.68
2018-02-14 13F-HR TEACHERS ADVISORS INC 16,500 16,500 0.00 441 463 4.99
2018-02-13 13F-HR Renaissance Technologies LLC 86,700 2,432
2017-10-27 N-Q Prudential Sector Funds, Inc. (see advisory)
2018-02-14 13F-HR STATE STREET CORP 97,669 123,642 26.59 2,613 3,468 32.72
2017-10-27 N-Q Stone Ridge Trust (see advisory)
2017-11-29 N-Q Deutsche Investments Vit Funds (see advisory)
2018-02-09 13F-HR Tower Research Capital LLC (TRC) 734 845 15.12 20 24 20.00
2018-02-01 13F-HR Nationwide Fund Advisors 5,263 0 -100.00 141 0 -100.00
2018-02-14 13F-HR BROWN BROTHERS HARRIMAN & CO 23,516 9,716 -58.68 629 273 -56.60
2018-02-14 13F-HR Stone Ridge Asset Management LLC 15,450 433
2018-02-14 13F-HR Bellevue Group AG 55,407 58,000 4.68 1,482 1,627 9.78
2018-02-14 13F-HR ROYAL BANK OF CANADA 753 1 -99.87 20 0 -100.00
2018-03-29 13F-HR/A-1 Marshall Wace LLP 0 11,391 0 320
2018-01-18 N-Q Jacob Funds Inc. (see advisory)
2018-01-26 N-Q Fidelity Concord Street Trust (see advisory)
2018-01-29 N-Q Sparrow Funds (see advisory)
2018-02-15 13F-HR Pier Capital, LLC 155,232 206,905 33.29 4,151 5,804 39.82
2018-02-28 N-Q Ivy Funds (see advisory)
2018-03-01 N-Q Sei Institutional Managed Trust (see advisory)
2018-02-14 13F-HR BANK OF AMERICA CORP /DE/ 10,614 33,425 214.91 284 938 230.28
2018-02-08 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 8,005 7,844 -2.01 214 220 2.80
2018-02-13 13F-HR JP Morgan Chase & Co 20,873 62,516 199.51 563 1,753 211.37
2018-02-06 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 9,500 21,902 130.55 254 614 141.73
2017-11-22 N-Q Manager Directed Portfolios (see advisory)
2018-02-02 13F-HR MEEDER ASSET MANAGEMENT INC 0 21 0 0
2018-02-13 13F-HR GEODE CAPITAL MANAGEMENT, LLC 95,686 109,260 14.19 2,558 3,064 19.78
2018-02-13 13F-HR Laurion Capital Management LP 0 48,203 0 1,352
2018-02-13 13F-HR Ranger Investment Management, L.P. 77,989 777,341 896.73 2,085 21,804 945.76
2018-03-01 N-Q Optimum Fund Trust (see advisory)
2018-02-14 13F-HR DSC Advisors, L.P. 80,000 2,244
2018-02-14 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 61,800 46,800 -24.27 1,653 1,313 -20.57
2018-02-14 13F-HR MILLENNIUM MANAGEMENT LLC 60,807 9,600 -84.21 1,626 269 -83.46
2018-02-13 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 10,000 10,000 0.00 267 281 5.24
2017-10-27 N-Q Forum Funds (see advisory)
2018-02-09 13F-HR Bank of New York Mellon Corp 27,802 66,295 138.45 743 1,860 150.34
2017-11-13 13F-HR RAYMOND JAMES & ASSOCIATES 58,750 0 -100.00 884 0 -100.00
2018-04-18 13F-HR Louisiana State Employees Retirement System 5,800 225
2018-02-14 13F-HR MORGAN STANLEY 17,602 28,952 64.48 471 813 72.61
2018-01-12 SC 13D/A Knowlton Calvin H 1,058,070 1,018,930 -3.70
2018-01-23 13F-HR STRS OHIO 0 4,900 0 137
2018-01-26 N-Q Amg Funds I (see advisory)
2018-02-15 13F-HR MEITAV DASH INVESTMENTS LTD 72,000 2,044
2018-02-14 13F-HR BLAIR WILLIAM & CO/IL 19,200 539
2018-02-09 13F-HR Monashee Investment Management LLC 4,296 2,027 -52.82
2017-11-22 N-Q Paradigm Funds (see advisory)
2018-04-11 13F-HR Taylor Wealth Management Partners 170,520 144,282 -15.39 4,783 5,598 17.04
2017-11-14 13F-HR Intrinsic Edge Capital Management LLC 30,654 0 -100.00 461 0 -100.00
2018-02-02 13F-HR Quadrant Private Wealth Management, Llc 20,300 569
2018-02-09 13F-HR RHUMBLINE ADVISERS 9,443 7,778 -17.63 253 218 -13.83
2017-11-02 13F-HR Boston Partners 235,180 0 -100.00 3,540 0 -100.00
2018-02-14 13F-HR Invesco Ltd. 11,815 81,910 593.27 316 2,298 627.22
2018-02-13 13F-HR O'SHAUGHNESSY ASSET MANAGEMENT, LLC 11,678 328
2018-04-16 13F-HR FINANCIAL CONSULATE, INC 8,295 8,295 0.00 233 322 38.20
2018-02-14 13F-HR PANAGORA ASSET MANAGEMENT INC 37,064 1,040
2018-02-14 13F-HR UBS Group AG 585 2,173 271.45 16 61 281.25
2018-04-05 SC 13G/A Originate Growth Fund 1a Lp 2,794,932 177,303 -93.66
2017-11-14 13F-HR CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. 2,900 0 -100.00 43 0 -100.00
2018-02-14 13F-HR GSA CAPITAL PARTNERS LLP 9,656 271
2018-02-05 13F-HR EMERALD ADVISERS INC/PA 391,814 390,582 -0.31 10,477 10,956 4.57
2018-01-16 13F-HR WASATCH ADVISORS INC 151,337 199,448 31.79 4,047 5,595 38.25
2018-04-09 13F-HR PARADIGM CAPITAL MANAGEMENT INC/NY 82,400 80,400 -2.43 2,311 3,120 35.01
2018-02-15 13F-HR Metlife Investment Advisors, Llc 4,962 139
2018-02-09 13F-HR BlackRock Inc. 412,906 425,027 2.94 11,042 11,922 7.97
2018-02-07 13F-HR Lebenthal Lisanti Capital Growth, LLC 29,105 24,645 -15.32 778 691 -11.18

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( TRHC / Tabula Rasa HealthCare, Inc. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 873379101